Clinical Trial Update: Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL [Phase 1]

View source ↗

Summary

HQP1351 is being investigated in a Phase 1 trial for patients with refractory chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Precursor Acute Lymphoblastic Leukemia
• Chronic Myeloid Leukemia
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• HQP1351

Snippet

Sponsor: Ascentage Pharma Group Inc. | Conditions: Leukemia, Myeloid, Chronic, Myeloid Leukemia | Phase 1 | Status: RECRUITING